TrialActa dermato-venereologica2021

Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study.

Marina Talamonti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.